An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
Conditions
Interventions
- DRUG: Dupilumab
- DRUG: placebo
- DRUG: ICS/LABA therapy
- DRUG: Salbutamol/albuterol
- DRUG: Levosalbutamol/levalbuterol
Sponsor
Sanofi
Collaborators